"No longer will older Americans be denied the healing miracle of modern medicine. No longer will illness crush and destroy the savings that they have so carefully put away over a lifetime"
Lyndon Johnson, July 30 1965, at the Medicare signing ceremony in Independence, Missouri A major economic rationale for social insurance is its potential to redress the consequences of market imperfections in private insurance markets. Public health insurance offers two potential benefits: direct risk-reduction benefits and indirect health benefits. As the above quotation highlights, both of these potential benefits figured prominently in the motivation for the establishment of the U.S. Medicare program.
Analysis of the impact of health insurance has focused primarily on only one of these potential benefits -the impact of insurance on health outcomes. In general, for the non-infant population, the evidence points strongly to no or only very modest health benefits (see e.g. Levy and Meltzer 2004 for a review of this literature). By contrast, the risk-reducing properties of health insurance, while at the core of any theoretical analysis of the benefits from insurance, have received comparatively little empirical attention.
In this paper, we demonstrate empirically that even in the apparent absence of health benefits, public health insurance can have important benefits from reducing risk exposure. These results suggest that the near-exclusive focus on health benefits in empirical analyses of the impact of health insurance can substantially understate the total benefits from health insurance provision.
We study the impact of the introduction of Medicare, which provides nearly universal public health insurance coverage to the elderly. The introduction of Medicare in 1965 was, and remains to date, the single largest change in health insurance coverage in U.S. history. Its introduction was followed by a substantial and prolonged decline in elderly mortality (see Figure 1 ). Nevertheless, using several different empirical strategies, we find no compelling evidence that, in its first 10 years, Medicare reduced overall elderly mortality. Our evidence suggests the explanation for this finding is that, prior to Medicare, elderly individuals with life-threatening, treatable health conditions sought care even if they lacked insurance, as long as they had legal access to hospitals.
However, although we detect no impact of the introduction of Medicare on overall elderly mortality, we estimate that its introduction is responsible for a striking and substantial decline in the large right-tail of the distribution of out of pocket medical expenditures for the elderly. Specifically, we estimate that
Medicare is associated with a forty percent decline in out of pocket spending for the top quartile of the out of pocket medical expenditure distribution; for the top decile of this distribution, the decline associated with Medicare is close to fifty percent.
Within a stylized expected utility framework, we simulate the welfare gains associated with this change in risk bearing and compare it to the costs associated with Medicare (both the moral hazard costs and the marginal cost of public funds). The results suggest that the magnitude of the welfare benefits from
Medicare's impact on consumption-smoothing may be considerable relative to the costs of the Medicare program; we estimate that the consumption-smoothing benefits may cover between one half and three quarters of Medicare's cost. This finding underscores the importance of considering risk reducing effects in any evaluation of the impact of health insurance.
The rest of the paper proceeds as follows. Section 1 provides some brief background on Medicare.
Section 2 analyzes the 10-year impact of Medicare on elderly mortality. Section 3 investigates the impact of Medicare on the distribution out of pocket expenditures. Section 4 uses these estimates to perform a cost-benefit analysis. The last section concludes.
Section 1: Background on Medicare
The U.S. Medicare program is one of the largest public health insurance programs in the world. Medicare was enacted in July 1965 and implemented essentially nationwide in July 1966. It provided virtually universal public health insurance to individuals aged 65 and older (coverage for the disabled was added in 1973). Individuals aged 65 and over are automatically enrolled in Medicare Part A, which covers up to 90 days of inpatient hospital expenses after an initial deductible and a 25 percent co-payment for days 61 -90; it is funded by a payroll tax. The elderly can choose to enroll in Medicare Part B, which covers physician costs after an initial deductible and 20 percent (uncapped) co-pay; it is funded partly by general revenues and partly by individual premiums which were designed to cover 50 percent of the program costs (Somers and Somers, 1967 ). Medicare's cost-sharing provisions and uncapped potential out of pocket spending make the extent of its consumption smoothing properties a priori uncertain.
Medicare's impact on health insurance coverage for the elderly was enormous, increasing by 75
percentage points the proportion of the elderly with any meaningful health insurance (Finkelstein 2005 ).
Recent empirical work has shown that the introduction of Medicare was associated with a substantial increase in health care utilization (Dow 2002 , Cook et al. 2002 , Finkelstein 2005 ) and spending (Finkelstein 2005) . In more recent times, Medicare coverage is also associated with a substantial increase in health care utilization (Lichtenberg 2002 , Decker and Rappaport 2002 , McWilliams et al., 2003 , Card et al., 2004 
Section 2: Medicare and Mortality
In this section, we examine the impact of the introduction of Medicare on elderly mortality through 1975. Mortality is, of course, only one measure of health. Our focus on mortality is motivated both by its importance and by the striking decline in elderly mortality rates that began shortly after the introduction of Medicare (see Figure 1) . From a practical standpoint, mortality is also one of the few objective, wellmeasured health outcomes; as a result, it is the focus of many of the studies examining the impact of health insurance on health (Levy and Meltzer, 2004) .
We use annual age-and state-specific mortality data from 1952 -1975 . Data from 1959 to 1975 are from the NCHS Multiple Causes of Death micro-data, which include the universe of death certificates;
prior to that, we use aggregate published death statistics (Vital Statistics, various years). Alaska and Hawaii are excluded from the analysis since they do not enter the data until 1959. We look up to 10 years after Medicare's introduction for any impact of Medicare on mortality; since health is a stock, the impact of a change in health insurance coverage on mortality might occur only with a lag.
Previous work on the impact of Medicare on health outcomes has used the age-variation in Medicare coverage to identify its effect, exploiting the fact that Medicare covers individuals over 65 but not under 65. This work points to, at best, very modest health benefits from Medicare, both at the time of its introduction (Dow 2002 , Cook et al., 2002 and in more recent times (Card et al., 2004) . Using the same age-based identification strategy, we also find no compelling evidence of an impact of the introduction of Medicare on elderly mortality (section 2.1). We explore two alternative sources of variation to further investigate Medicare's impact. In Section 2.2, we exploit geographic variation in the increase in insurance coverage associated with Medicare's introduction. In Section 2.3, we exploit variation in the timing of Medicare's implementation in certain Southern counties.
These additional empirical strategies serve two purposes. First, each of the three approaches has its own strengths and weaknesses, which we discuss below. Our finding of similar results from the three different empirical strategies therefore increases our confidence in the conclusion that Medicare appears to have had no impact on overall elderly mortality in its first 10 years. Second, the combined evidence from the three strategies helps shed light on why Medicare appears to have had only modest health benefits at best; we discuss this in more detail in section 2.3 below.
Mortality estimates based on Medicare's coverage by age
Figure 2 shows trends in mortality rate for the "young elderly" (aged 65-74) who become covered by (1) Our dependent variable is the log of the number of deaths in state s and year t in age group a. For the right hand side population variable, we construct annual, state-and age-group-specific population estimates by fitting separate cubics to the 1950 through 1980 census data for each state-age group cell. In practice, the results are not sensitive to using the log of the death rate or the death rate as the left hand side variable.
We include an indicator variable ( a elderly ) for whether the deaths are for the young-elderly rather than the near-elderly, and a series of state and year fixed effects (1(State s ) and 1(Year t ) respectively). 
ln(deaths).
Medicaid, the public health insurance program for the indigent was, like Medicare, also enacted in July of 1965. However, the timing of Medicaid implementation -unlike that of Medicare -was left up to the individual states (see Gruber, forthcoming for details). We control for any impact of Medicaid on health outcomes by including a series of indicator variables ( st X ) for the number of years since (or before) the implementation of a Medicaid program in state s. In practice, the results are not sensitive to these controls, which is not surprising given that the relative impact of Medicaid (compared to Medicare) on the elderly was quite small (National Center for Health Statistics 2002 and Holahan 1975) .
We report results from weighted estimation of equation (1) λ from estimating equation (1). The level of the graph is arbitrary; we set it at 0 in 1966, the omitted year. It indicates that although mortality for the young elderly is declining relative to that of the near-elderly after Medicare, this decline begins in 1962, four years before Medicare is implemented; moreover, this relative mortality decline for the young elderly reverses in the mid 1970s.
The visual impression of no compelling evidence of an impact of Medicare on young elderly mortality relative to near elderly is confirmed by statistical tests (not shown). We also found no evidence of an impact of Medicare for specific diseases -such as cardiovascular disease -or for sub-populations where we might expect a bigger impact of Medicare on health: non-whites -who are among the most vulnerable in the population -and individuals in urban areas -where availability and access to medical care is much greater than in rural areas (not shown).
Mortality estimates based on geographic variation in insurance prior to Medicare
The age-based identification strategy is not well-suited to examining the impact of Medicare on mortality for the oldest of the elderly, for whom Medicare might conceivably have a larger mortality impact. In addition, the age-based strategy will be biased against finding an impact of Medicare if the treatment of individuals just under age 65 is affected by the insurance coverage Medicare provides to all individuals over age 65. Physician practice norms, concerns about malpractice liability, or joint costs of the production of health care could all contribute to "health insurance spillovers"; Baker (1997), Hellerstein (1998) and Glied and Zivin (2002) present evidence consistent with such spillovers.
We therefore employ an alternative strategy based on the substantial geographic variation in private health insurance coverage among the elderly prior to the introduction of Medicare. 
The variables are defined as in equation (1) (2) by OLS using the square root of the population in state s and year t for weights.
Unweighted estimates (not reported) are very similar. We adjust our standard errors to allow for an arbitrary covariance matrix within each state over time.
We present results using the Blue Cross measure since, unlike most other forms of health insurance for the elderly, Blue Cross insurance provided meaningful coverage. In addition, Medicare benefits were explicitly modeled after these plans (Anderson et al. 1963 , Ball 1995 , Newhouse 2002 . In practice the results are not sensitive to the choice of health insurance measure (not shown). and over, mortality rates were rising in areas with less insurance relative to the areas with more insurance prior to the introduction of Medicare; this is not surprising since areas with less insurance are also poorer.
The identifying (or, counterfactual) assumption is that, absent Medicare, the differential trend in mortality improvements would have continued. Any systematic divergence from this differential trend after 1966 would suggest an impact of Medicare. However, there is no indication of any divergence. In results not reported, we implemented statistical tests that confirm this visual impression. Again, we also found no evidence of an impact of Medicare for specific diseases -such as cardiovascular disease -or for two subpopulations where health insurance might have been expected to have more of an impact on health: nonwhites or individuals living in urban areas (not shown).
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One of the advantages of using the geography-based identification strategy instead of the age-based identification strategy is the ability to look at the effect of Medicare separately for different age groups.
Panels B and C of Figure 4 therefore report results separately for, respectively, individuals aged 65-74 and individuals aged 75 and over. For neither age group is there evidence of any differential decline in mortality rates in areas where insurance coverage increased more as a result of Medicare's introduction. Indeed, the results for individuals aged 65-74 suggest that Medicare is associated with an increase in mortality rates, while results for individuals aged 75+ indicate no impact of Medicare in either direction.
Statistical tests (not reported) confirm this visual impression.
A concern with using geographic variation in private insurance coverage to identify the impact of Medicare is that the mid-1960s through early 1970s were a period of innovation in the treatment of 2 In principle, the impact of Medicare varies not only according to the percent of the elderly without insurance but also the percent of the elderly in the area. In practice however, there is very little variation even across counties in the percent elderly. 3 The results are also robust to a number of other specifications such as a linear rather than log-linear model, estimating the model separately by gender, excluding one subregion at a time, excluding all four Southern subregions at once, and excluding the Medicaid control variables (not shown). cardiovascular disease, including new information about the risks of smoking and the development of anti-hypertensives (Cutler and Kadiyala 2003) . If individuals in richer areas were more likely to adopt these health care innovations, this would bias our estimates of the mortality benefits of Medicare downward, since richer areas also had higher pre-Medicare insurance rates and thus a lower estimated impact of Medicare. To address this issue, we performed a triple-difference analysis by combining the age-based variation in the previous subsection with the geographic identification strategy used in this subsection. This analysis also yields no statistical or substantive impact of Medicare on mortality (results not shown).
Why did Medicare have no overall effect on mortality in its first 10 years? Evidence from the segregated South
The above evidence suggests that -at least in its first 10 years -Medicare played essentially no role in the dramatic decline in mortality rates for the elderly that began in the late 1960s. Since Medicare was associated with a substantial increase in the elderly's use of hospital care (Dow 2002 , Cook et al. 2002 , Finkelstein 2005 , this implies that the Medicare-induced increase in health care consumption was ineffective, at least for mortality. Our third empirical approach sheds some light on why this was the case. This third approach is based on the fact that for a hospital to be eligible to receive Medicare funding, it had to be racially desegregated. As a result, the implementation of Medicare increased non-whites' access to hospitals in segregated parts of the South (Smith, 1999; Almond et al., 2003) . It also resulted in Medicare-certified hospital in county c at time t. We adjust our standard errors to allow for an arbitrary covariance matrix within each county over time.
We estimate equation (3) separately by race, and within race by disease. As a result of this fine cutting of the data, a reasonably high proportion of counties has no deaths in a given year. We therefore report results in which the death rate (in levels) is the dependent variable as well as results in which ln(deaths) is the dependent variable and ln(population) is included on the right hand side. Table 2 reports the results. The first two columns indicate that the introduction of Medicare had no discernible impact on overall elderly mortality in the Mississippi delta, either for non-whites (Panel A) or whites (Panel B). However, the next two columns suggest that the introduction of Medicare is associated with a statistically significant decline in non-white elderly pneumonia mortality rates. There is no evidence of comparable effects for whites, or for other diseases. For example, the last two columns indicate no impact of Medicare on a decline in mortality from cardiovascular disease, which accounted for two-thirds of elderly deaths in 1965; improvements in cardiovascular disease mortality were also the primary cause of the decline in elderly mortality starting in the late 1960s (Cutler and Kadiyala 2003) .
Although statistically significant, the impact of Medicare on non-white elderly pneumonia mortality is substantively small. The point estimates suggest that Medicare is associated with a 35 percent (loglinear specification) or 0.1 percentage point (linear specification) decline in non-white elderly pneumonia deaths. Only 3.3% of elderly deaths in 1965 were from pneumonia; therefore even the larger estimate suggests that Medicare reduced non-white elderly overall mortality in these counties by only 1 percent.
By contrast, pneumonia-related deaths were over one-quarter of infant deaths. This explains why Almond et al. (2003) estimate a substantially larger impact of Medicare on non-white post-neonatal mortality than we do for non-white elderly mortality, even though Medicare provided insurance coverage to the nonwhite elderly in addition to the access to hospitals it provided to non-whites of all ages.
More generally, these findings help explain our estimates that Medicare appears to have had little or no effect on overall elderly mortality. At the time of Medicare's introduction, hospitals were primarily effective at treating short-term acute illness, rather than chronic disease (Somers and Somers 1961) . Our findings suggest that -apart from non-whites who were denied access to hospital care in some places prior to Medicare -individuals with pneumonia and other infectious diseases that hospitals could treat effectively at the time were likely to seek medical care regardless of insurance status. This explains why we find evidence of an impact of Medicare's introduction on the elderly non-white pneumonia mortality rate in the segregated South -where the introduction of Medicare opened up access to hospitals for these individuals -but not for whites in the same areas (despite their low insurance coverage prior to Medicare), since whites already had legal access to these hospitals. It also explains why we find no discernable impact of Medicare's introduction on the elderly pneumonia mortality rate for either race using either the age-based or geography-based identification strategy (not shown).
If, prior to Medicare, individuals sought hospital care where it was likely to be effective regardless of insurance coverage, they must have paid out of pocket and/or relied on charity care. Consistent with this, the next section documents a large amount of out of pocket medical spending by the elderly prior to Medicare.
Section 3: Medicare and Exposure to Out-Of-Pocket Medical Expenditure Risk
To examine the impact of Medicare on out of pocket expenditure risk, we use data on health care expenditures from the 1963 and 1970 Surveys of Health Service Utilization and Expenditures. These data contain information on health care expenditures for 7,802 individuals in 1963, and 11,619 in 1970. For much of the analysis, we limit the sample to the 3,030 individuals aged 55-74 in either year. 4 The data contain detailed information on medical spending both by type of spending (e.g. hospital, physician, drug) and by source of payment (out of pocket, private insurance, public insurance, and total).
5 Table 3 provides some descriptive statistics on the medical spending by the elderly in 1963, prior to the introduction of Medicare. All dollar estimates in this and subsequent tables are converted to 2000 dollars using the CPI-U. At $844, average annual per capita medical spending by the elderly in 1963
represented over 10 percent of income. Over 90 percent of this spending was paid out of pocket, and 60 percent of these out of pocket expenditures were for medical services that subsequently became covered by Medicare (i.e. doctor and hospital expenditures); the rest were for drugs, primarily prescription drugs.
6 Figure 5 indicates that there was a substantial right tail to the distribution of elderly out of pocket medical expenditures in 1963 that would subsequently be covered by Medicare, a finding that to our knowledge has not been previously demonstrated. This right tail also persists when we examine the distribution of out of pocket medical spending as a percentage of income (not shown).
Our empirical strategy is to compare changes in spending for individuals over age 65 to changes in spending for individuals under age 65 between 1963 and 1970. To increase the plausibility of the identifying assumption that, absent Medicare, changes in various types of spending for individuals above and below age 65 would have been the same, we focus primarily on changes in spending for the young elderly (ages 65 to 74) relative to that for the near elderly (ages 55 to 64). For all of the spending categories we examine, mean spending in 1963 is substantively quite similar and statistically indistinguishable for the two age groups.
The confounding effect of the introduction of Medicaid likely biases down our estimates of the impact of Medicare on increasing total spending and reducing out of pocket spending. Medicaid was also introduced between 1963 and 1970, and Medicaid spending is higher for the near-elderly (our control group) than the young-elderly (our treatment group); unlike in the mortality analysis, we do not have geographic identifiers and therefore cannot exploit the variation across states in the timing of Medicaid introduction; we also cannot use the geographic variation in Medicare's impact on insurance to identify its effects on out of pocket medical expenditure risk.
Impact of Medicare on mean spending
Although our primary interest is in the impact of Medicare on the distribution of out of pocket spending, we begin with a brief analysis of the impact of Medicare on average spending of different types. Our basic estimating equation is:
In this standard difference-in-differences framework, the coefficient of interest is 3 β ; it indicates the differential change in spend iat between 1963 and 1970 for individuals aged 65 to 74 relative to individuals aged 55 to 64. The covariates (X iat ), consist of age, age squared, and indicator variables for male, married and education group (6 years of school or less, between 6 and 12 years, or 12 or more years of school); in practice, the results are virtually identical without these controls (not shown). We estimate equation (4) Table 4 reports the results for various Medicare-eligible spending categories. The first column indicates that the introduction of Medicare is associated with a decline in mean out of pocket spending of $117. This represents a one-quarter decline from the out of pocket spending by the young elderly in 1963, but is not statistically significant. The estimated decline in mean out of pocket spending on physicians shown in the third row is statistically significant and corresponds to about a one-third decline. These estimates are somewhat smaller than estimates of the impact of other social insurance programs on risk 7 In results not reported, we found that the p-values are essentially unaffected if we instead implement the randomized inference approach of Bertrand, Duflo and Mullainathan (2004) . reduction. For example, Gruber (1997) estimates that the public unemployment insurance system reduces the fall in consumption associated with an unemployment spell by about two-thirds. However, we will show below that these estimates of the impact of Medicare on average out of pocket spending mask Medicare's real impact, which is concentrated in the right tail of out of pocket spending.
The remaining three columns suggest that Medicare is associated with declines in private insurance spending, and increases in total insurance spending and total spending. Although the increase in total spending is not statistically significant, the point estimate implies that Medicare was associated with a 28 percent increase in total medical spending. Interestingly, the estimates from the RAND health insurance experiment would also predict that the introduction of Medicare would be associated with a 28 percent increase in medical spending (Newhouse 1993 , Finkelstein 2005 ).In results not reported, we also found no evidence of an impact of Medicare on drug spending, which Medicare does not reimburse.
The possibility, discussed above, that the introduction of Medicare may have spillover effects on health spending of the non-elderly could bias downward our estimates of the impact of Medicare on the increase in total health spending, as the control group of near-elderly could also experience some increased spending associated with Medicare. Of course, such spillovers could also bias upward our estimate of the impact of Medicare on reducing out of pocket spending of the elderly if the spillovers induced increased out of pocket spending by the near-elderly. While we cannot rule out this possibility, we note that the time series evidence does not seem to suggest such an effect: there is no statistical or substantive change in mean out of pocket spending for the near elderly. Figure 6 similarly indicates that the distribution of out of pocket spending did not change for the near elderly between 1963 and 1970.
The difference-in-difference estimates of the impact of Medicare on out of pocket spending by the young elderly are thus virtually identical to the simple time series difference. To adjust for covariates, we replace the centile from the spending distribution with the centile from the distribution of spending residuals from a linear regression of spending on the covariates described above.
Effect of Medicare on the out of pocket spending distribution: centile treatment estimates
We calculate confidence intervals for our estimates using the empirical standard deviation of 200 bootstrap replications of the quantile treatment estimates.
The results are shown without covariate adjustment ( Figure 7a ) and with covariate adjustment ( Figure   7b ). The results are striking. There is no evidence of an impact of Medicare on out of pocket spending until the top quartile of the out of pocket spending distribution. For this top quartile, the declines are dramatic, and increase monotonically throughout the quartile. Table 5 Figures 7c and 7d show that the quantile treatment estimates look similar if we expand the elderly sample to include all those aged 65 -90. Because we will use these estimates from the larger sample for the welfare analysis below, these point estimates are also reported in columns 5 and 6 of Table 5 .
The quantile treatment estimator in equation (5) uses as a proxy for the change in spending that would have occurred for spending quantile q in the treatment group absent the introduction of Medicare, the change in spending that did occur for the same quantile q in the control group. An alternative estimator suggested by Athey and Imbens (2003) uses as a proxy for the change in spending that would have occurred for spending level y in the treatment group absent the introduction of Medicare, the change in spending that did occur in the control group at the quantile in the control group that corresponds to that same level y. Given the similarity of the treatment and control distributions in the pre-period (see Figure   6 ), we find, not surprisingly, that the two approaches yield very similar results (not shown).
A potential concern with the foregoing analysis is that it assumes that, absent the introduction of Medicare, out of pocket spending at the top of the distribution would not have declined for the youngelderly relative to the near-elderly. We provide some indirect support for this identifying assumption. These findings suggest that our main analysis comparing 65-74 year olds to 55-64 year olds is not merely picking up an underlying change in the spending distribution that differs systematically by age.
Section 4: Cost benefit analysis
We use a stylized expected utility framework to simulate the insurance value of the estimated reduction in risk exposure associated with Medicare and compare this to the estimated costs of Medicare, which consist of the moral hazard costs of any induced health care consumption as well as the marginal cost of public funds for Medicare expenditures. 9 Estimation of the insurance value of Medicare requires that we make a number of modeling assumptions. While we therefore consider our findings here more speculative than the results in the previous section, we believe they provide a useful way to gauge the likely magnitude of the welfare benefits associated with Medicare's reduction in risk exposure.
The insurance value of Medicare
Our analysis of the insurance value of Medicare is similar in spirit to McClellan and Skinner (1997) , who analyze the relative insurance value of Medicare for individuals at different parts of the income distribution. However, while McClellan and Skinner (1997) use the expected utility model and parametric assumptions about the price and income elasticity of demand for medical care to solve for the optimal consumption of medical care in the presence and absence of Medicare, we instead use our empirical estimates of the distribution of medical expenditures before and after Medicare as inputs into the expected utility framework.
We assume the individual's utility ) (c u is a function of his non-health consumption ) (c . We assume the individual must satisfy a period-by-period budget constraint:
where y is his per-period income (such as from Social Security) and m is his out of pocket medical expenditures. m is a random variable with probability density function ) (m f To calculate the welfare gain associated with increased health insurance coverage, we follow the general approach used in the existing literature that calculates the welfare gains associated with other insurance products (e.g. Mitchell et al. 1999, Brown and Finkelstein, 2004 and Feldstein and Gruber, empirical evidence of adverse selection in private health insurance markets also supports our assumption of underinsurance (Cutler and Zeckhauser 2000) . We do not consider the distributional impact of Medicare, which is analyzed by McClellan and Skinner (1997) and Bhattacharya and Lakdawalla (2002). 1995) . Specifically, we compute the individual's risk premium under both the pre-and post-Medicare spending distributions. The risk premium (π) is the maximum amount that a risk averse individual would be willing to pay to completely insure against the random variable m . The risk premium π is therefore defined implicitly by:
A decrease in risk exposure in the post-Medicare world relative to the pre-Medicare world will appear as a decline in the risk premium; this decline provides a measure of the insurance value (and hence welfare gain) of the Medicare coverage.
We assume a constant relative risk aversion utility function. For our central estimate, we follow a long line of simulation literature of the value of social insurance for the elderly and assume a coefficient of relative risk aversion of 3 (see e.g. Hubbard, Skinner and Zeldes 1995 , McClellan and Skinner 1997 , Mitchell et al. 1999 . However, in recognition of the range of plausible parameters, we also report results for coefficients of risk aversion of 1 and of 5.
Our analysis is based on the sample of 658 individuals aged 65 and over in 1963. We construct individual income by dividing the household income reported in the data by the number of individuals in the household. For each individual, we make 50 random draws without replacement from his potential out of pocket spending distribution. Since pre-Medicare out of pocket medical expenditures are strongly positively correlated with household income, we divide our individuals into income terciles and make the 50 draws for a given individual from the out of pocket expenditure distribution of his income tercile.
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The first column of Table 6 shows the average risk premium when each individual faces the original out of pocket expenditure distribution that existed prior to Medicare. For a coefficient of relative risk 10 Even with tercile-specific draws, it is still possible to get a draw that is very high relative to (or higher than) income, which is unrealistic relative to actual spending patterns. Empirically, the 95 th percentile of the distribution of out of pocket spending as a share of income for individuals in the bottom tercile of the income distribution is 80%, so we cap out of pocket spending as a fraction of income for each draw at 80%. Using this approach, roughly onethird of individuals have at least one draw capped. As a result, the mean out of pocket Medicare-eligible expenditures as a percent of income in our simulation is somewhat lower than in the actual distribution (0.06 compared to 0.08), which suggests that we may underestimate the risk reduction associated with Medicare. aversion of 3, the risk premium is $953, indicating that this individual would be willing to pay up to $953 to avoid any future out of pocket medical expenditure risk. This willingness to pay is more than double the reduction in average out of pocket spending ($412).
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The second column shows the decrease in risk premium associated with moving from the original, pre-Medicare distribution to the out of pocket spending distribution the individual faces once the quantile treatment estimates of Medicare's impact are applied. We make this adjustment based on our quantile treatment estimates of the reduction in out of pocket medical spending associated with Medicare for individuals aged 65 and over (see Figure 7c) . To separate out the insurance value from the windfall intergenerational transfer, we recalculate the postMedicare risk premium under the assumption that individuals must "pay for" the actuarial expected value of Medicare. Specifically, we subtract from the individual's income the average difference in out of pocket expenditures between his 50 draws for the original pre-Medicare distribution and his 50 draws from the post-Medicare distribution. Column 3 shows the change in risk premium associated with moving from the pre-Medicare distribution to the post-Medicare distribution when this insurance is "actuarially fair"; for a coefficient of relative risk aversion of 3, the results in column 3 indicate a welfare gain of $236 per person, or just over half the welfare gain without accounting for the windfall (column 2).
These results understate the decline in risk exposure associated with Medicare coverage because they incorporate the behavioral response to Medicare. Both the income and substitution effect from Medicare lead to increased consumption of health care and hence out of pocket spending. This increased out of pocket risk reflects individual optimization decisions, and therefore should not be counted against the welfare gain. (Of course, the behavioral response does contribute to the costs of the program, and we therefore account for these moral hazard costs in the cost-benefit analysis below.)
To abstract from the behavioral response to Medicare in calculating the insurance value, we estimate the post-Medicare out of pocket spending distribution by mechanically adjusting the pre-Medicare 1963 distribution to account for what Medicare would have covered had Medicare existed in 1963.
12 Figure 9 shows this mechanically adjusted distribution; for comparison, it also shows the pre-Medicare distribution and the pre-Medicare distribution adjusted using the quantile treatment estimates. As expected, the mechanical adjustment produces a distribution that lies below that from the quantile treatment adjustment.
Columns 4 and 5 of Table 6 report the welfare benefits using the mechanical adjustment to estimate the post-Medicare out of pocket spending distribution. Column 4 shows the change in risk premium when individuals are given Medicare "for free" while column 5 reports the results under the assumption that individuals must "pay for" the actuarial expected cost of Medicare. In both cases, the decline in risk premium associated with Medicare is larger than that estimated using the quantile treatment adjustment.
For a coefficient of relative risk aversion of 3, the results in column 5 indicate that the mechanical introduction of Medicare (at actuarially fair rates) is associated with a welfare gain of $519 per person.
There were about 19 million people aged 65 and over in 1965. This implies that Medicare's reduction in risk exposure was associated with $9.9 billion per year in welfare gains.
For several reasons, the estimates in Table 6 may be underestimates of the consumption smoothing benefits associated with Medicare. The stylized model treats medical expenditures as affecting the budget constraint only and does not allow for any utility from increased medical expenditures. While some of the increased spending associated with Medicare may have been socially inefficient, the cost-sharing provisions ensure that its social marginal benefit was not zero. In addition, to the extent that some of the elderly's medical expenditures were paid for by their adult children in the pre-Medicare era, Medicare may have had additional consumption smoothing benefits for this other group of individuals. Finally, out of pocket medical expenditures are likely to be positively serially correlated, suggesting that the lifetime distribution of out of pocket spending for those aged 65 and over may be even more right-skewed than the annual distribution shown in Figure 5 ; as a result, Medicare's reduction in risk exposure may be even greater when estimated from on a lifetime rather than annual basis.
In one important respect, however, the estimates in Table 6 may overestimate the value of Medicare.
Our analysis assumes that the individual cannot borrow or save across periods but must consume each period their net-of-medical expenditures income. This may be a reasonable assumption for many elderly households, since many enter retirement with relatively little financial assets. Indeed, our calculations from the 1962 Survey of Consumer Finances (SCF) suggest that almost one-third of elderly households had no liquid assets whatsoever, and many of those who do have liquid assets have relatively small amounts. However, at the high end of the wealth distribution, savings might be an important form of consumption smoothing and failure to account for them will result in an overstatement of the insurance value of Medicare for these individuals. Nonetheless, we believe that our per-person welfare estimate is likely to be a reasonable approximation for much of the wealth distribution. 
Comparison to estimated costs
Medicare imposes two types of costs. First, there is the cost of raising the revenue to pay for the public program. In 1970, Medicare spending was (in 2000 dollars) $34 billion. The consensus estimate of 0.3 for the marginal cost of public funds in the US (Poterba, 1996) implies that the annual revenue raising costs associated with Medicare were $10.2 billion. Second, there are the efficiency costs from the increased health spending due to the moral hazard associated with health insurance. By treating all of the increase as a cost, we provide an upper bound on the efficiency costs of Medicare, since part of the moral 13 We re-calculated welfare gains separately for each income tercile to confirm that our estimate of the average perperson welfare gain is not driven by disproportionate gains at the top of the distribution where we are likely to be over-estimating the gain. Indeed, per-person welfare gains were slightly higher for individuals in the lower portions of the distribution; for example, we estimated a welfare gain of $482 for the top income tercile for "actuarially fair" Medicare with risk aversion of 3, compared to a welfare gain of $523 for the bottom tercile.
hazard effect comes from the income effect of health insurance, which does not have efficiency costs. The moral hazard estimates in section 3.1 -which suggest that Medicare is associated with a 28 percent increase in the elderly's health spending -imply that Medicare is associated with a moral hazard cost of $2.8 billion.
14 The four-fold larger moral hazard estimates in Finkelstein (2005) imply that Medicare is associated with a moral hazard cost of $11.2 billion.
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Combining the moral hazard and public funds costs suggests that the annual cost of Medicare was $13 to $21.4 billion. Using a risk aversion coefficient of 3, we estimated above that the consumption smoothing benefits from Medicare were worth roughly $9.9 billion annually. Thus, the direct insurance benefits cover between forty-five and seventy-five percent of the costs of the program.
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Section 5: Conclusion
This paper has examined the impact of the introduction of Medicare, the single largest change in health insurance coverage in U.S. history. Using several different empirical approaches, we find no evidence that the introduction of nearly universal health insurance for the elderly had an impact on overall elderly mortality in its first 10 years. These results are particularly surprising in light of the fact that the introduction of Medicare was followed by a period of prolonged and substantial declines in elderly mortality. The evidence suggests that insurance coverage provided by Medicare did not contribute to this mortality decline because prior to Medicare lack of legal access, rather than lack of insurance, was the main barrier to receiving hospital care when individuals had life-threatening, treatable conditions.
We also find that, although Medicare did not produce measurable mortality benefits, it did provide considerable risk reduction benefits. We estimate that the introduction of Medicare was responsible for a striking and substantial decline in the right-tail of the out of pocket medical expenditure distribution for the elderly. For the top quartile of out of pocket medical spending, we estimate that the introduction of 14 There were about 19 million people aged 65 and over in 1965 and their average per capita Medicare-eligible health spending in 1963 was $518 (see Table 3 ). 15 One reason for the larger estimates is that estimates -such as those in this paper -based on the age variation in Medicare coverage will be biased downward if Medicare affects health spending among the "control group" of individuals aged 55 to 64. See Finkelstein (2005) for a more detailed discussion of this issue. 16 Using data from the Health and Retirement Survey in the 1990s, Khwaja (2005) also estimates substantial riskreducing benefits from Medicare relative to the costs of the program.
Medicare is associated with a forty percent decline in out of pocket spending relative to pre-Medicare levels. A stylized expected utility framework suggests that the welfare gains associated with this reduction in risk bearing are substantial, and may be sufficient to cover between half and three quarters of the costs associated with the Medicare program.
Our empirical findings underscore the importance of considering the direct consumption smoothing benefits of health insurance, in addition to any indirect benefits from the effect of insurance on health.
Relatedly, they suggest that the extensive empirical literature devoted to estimating the health benefits of health insurance -which has tended to find no or only modest benefits for adults -may be substantially underestimating the total benefits from health insurance.
The analysis of this paper is done in a static environment in which medical technology is taken as given. However, Finkelstein (2005) presents evidence that Medicare may have played an important role in the adoption of new medical technologies. The increase in life expectancy from these new technologies is extremely large . This raises the interesting and important possibility that, although we found no compelling evidence of an impact of Medicare on mortality in its first 10-years, the longer-run impact of Medicare on mortality via induced technological change may be substantially larger. A critical issue, however, is how the marginal benefits of any new technology use induced by Medicare compare to the average benefits discussed by . We consider this an important area for further research.
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